comparemela.com

Latest Breaking News On - Fully compensated - Page 1 : comparemela.com

ABIONYX Pharma Announces the Completion of a Contribution in Kind to the Company of 100% of the Capital of IRIS Pharma Holding, Fully Compensated by the Issue of New Shares at a Price of €3 60 Per Share to Become a Specialist of Bioproducts

IRIS Pharma becomes a subsidiary of ABIONYX Pharma and remains independent in its service activities for major pharmaceutical and biotech companies in the ophthalmology sector A potential

United statesJean louis dasseuxLuc demarreYann quentricPierre paul elenaArthur rouillIris pharmaCyrille tupinChristian chavyLouis victor delouvrierM emmanuel huynhSadok belmokhtarPharma holdingIris pharma holdingFully compensatedNew shares

ABIONYX Pharma Announces the Completion of a Contribution in Kind to the Company of 100% of the Capital of IRIS Pharma Holding, Fully Compensated by the Issue of New Shares at a Price of €3 60 Per Share to Become a Specialist of Bioproducts - Press Release

IRIS Pharma becomes a subsidiary of ABIONYX Pharma and remains independent in its service activities for major pharmaceutical and biotech companies in

United statesIris pharmaPharma holdingFully compensatedNew sharesNorth america

vimarsana © 2020. All Rights Reserved.